NSE - SMEListed
Sotac Pharmaceuticals Limited

Sotac Pharmaceuticals Limited

Company website
Sotac Pharmaceuticals Limited is going public with an issue of ₹30,00,000 crore. The fresh portion of ₹30,00,000 crore typically funds growth or debt reduction.
The OFS of ₹0 crore provides liquidity to selling shareholders. Apply between 29-03-2023 and 03-04-2023; allotment expected on 10-04-2023.
Start Date29-03-2023
End Date03-04-2023
Listing Date13-04-2023
Allotment Date10-04-2023
Current Price₹115
GMP₹0 (0.00%)
Lot Size1200 Shares
Subscription1.6 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹105 - ₹111
Pre Issue₹80,50,000
Post Issue₹1,10,50,000
Issue Size₹30,00,000
(aggregating up to 33.30 Cr)
Fresh Issue₹30,00,000
(aggregating up to 33.30 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Sotac Pharmaceuticals Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹105 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
12 Nov 2025, 06:11
₹111
₹0
₹111 (0.00%)
21 Mar 2025, 08:40
₹111
₹0
₹111 (0.00%)

Financials overview In Lakhs

Here is a quick look at the recent financial performance of Sotac Pharmaceuticals Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIValues
EPS
0
ROE
6.38
ROCE
19.03
RONW
0
PRE IPO(PE)
132.14
POST IPO(PE)
0
The IPO reservation for Sotac Pharmaceuticals Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
QIB
47.44%
14,23,200
NII (HNI)
14.28%
4,28,400
RETAIL
33.28%
9,98,400
Market Maker
5.00%
1,50,000
TOTAL
100.00%
30,00,000

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
1
1,200
₹1,33,200
0
HNI
2
2,400
₹2,66,400
0
Below you can find the official contact details of Sotac Pharmaceuticals Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 90819 93300
Address: Plot No. PF-21, Nr. ACME Pharma, Opp. Teva Pharma Sanand GIDC-II, Sanand Ahmedabad - 382110

IPO Registrar

Name: Kfin Technologies Limited
Phone: 04067162222